Core support for the immune cell network
Active Awarded Last action
- Contract number
- 75N91021F00015
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,946,544
Award facts
- Contract value 100% obligated
- $26,946,544.00 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $6,520,799 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $14,407,995 | |
| Other Administrative Action | $0 | |
| Original award | $6,017,750 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 16, 2021, for core support of the Immune Cell Network, with a ceiling value of $26.9 million.
Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of December 31, 2027.
Service Contract Inventory reporting shows this order's labor footprint has expanded significantly. In FY2025, the order invoiced $7.6 million across 17.1 FTEs and 35,544 contractor hours, with a blended government-paid hourly rate of $213.06/hr. FY2024 invoiced $1.9 million across 11.7 FTEs and 24,273 contractor hours at $79.87/hr. FY2023 invoiced $495 thousand across 2.3 FTEs and 4,777 contractor hours at $103.70/hr. FY2022 invoiced $386 thousand across 1.8 FTEs and 3,655 contractor hours at $105.75/hr. FY2021 invoiced $313 thousand. Teaming depth in FY2025 was minimal—one subcontractor accounted for 5% of contractor hours, with the remainder performed in-house.
Quick answers
Who was awarded contract 75N91021F00015?
75N91021F00015 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2021.
How much is contract 75N91021F00015 worth?
The government has obligated $26,946,544 on 75N91021F00015.
Is contract 75N91021F00015 an order under another contract?
Yes. 75N91021F00015 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00015 competed?
The extent of competition for 75N91021F00015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award